NCT01438411View on ClinicalTrials.gov

Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis

PHASE3CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Bile Acid Synthesis Defect
Interventions
DRUG

Cholic Acid

10-15 mg/kg body weight/day supplied in 50 or 250 mg Cholic Acid Capsules

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

Sponsors
All Listed Sponsors
lead

Mirum Pharmaceuticals, Inc.

INDUSTRY